Prices delayed by at least 15 minutes | Print
Ishares Vi PLC ISH MSCI EPE HCS ACC
Open
£6.797
Previous close
£6.824
Trade high
£6.797
Income frequency
-
Year low
£5.55
Year high
£6.868
Replication method
Physical Full
Volume
6,717
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.18
ISIN
IE00BMW42181
Share price
Asset allocation
Top 10 holdings
| Holdings 13/11/2026 | % of assets |
|---|---|
| Roche Holding AG Ordinary Shares new | 17.20 |
| Novartis AG Registered Shares | 14.85 |
| AstraZeneca PLC | 14.17 |
| Novo Nordisk AS Class B | 6.71 |
| Sanofi SA | 5.35 |
| GSK PLC | 5.18 |
| Bayer AG | 3.11 |
| argenx SE | 3.07 |
| Essilorluxottica | 2.96 |
| Lonza Group Ltd | 2.83 |
Investment objective
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the MSCI Europe Health Care 20/35 Capped Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the MSCI Europe Health Care 20/35 Capped Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all of the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.